Faculty Collaboration Database

Epigenetic modifications in pediatric acute lymphoblastic leukemia. Front Pediatr 2014;2:42

Date

05/27/2014

Pubmed ID

24860797

Pubmed Central ID

PMC4030177

DOI

10.3389/fped.2014.00042

Abstract

Aberrant epigenetic modifications are well-recognized drivers for oncogenesis. Pediatric acute lymphoblastic leukemia (ALL) is no exception and serves as a model toward the significant impact these heritable alterations can have in leukemogenesis. In this brief review, we will focus on the main aspects of epigenetics, which control leukemogenesis in pediatric ALL, mainly DNA methylation, histone modification, and microRNA alterations. As we continue to gain better understanding of the driving mechanisms for pediatric ALL at both diagnosis and relapse, therapeutic interventions directed toward these pathways and mechanisms can be harnessed and introduced into clinical trials for pediatric ALL.

Author List

Burke MJ, Bhatla T

Author

Michael James Burke MD Professor in the Pediatrics department at Medical College of Wisconsin